What is the market size of psoriasis | Industry Trends & Forecast 2026

What is the size of the psoriasis market?

The market is experiencing growth due to the rising prevalence of psoriasis worldwide. Continuous advancements in biologic therapies are improving treatment effectiveness and patient outcomes. Additionally, increasing awareness about the disease and available treatment options is driving early diagnosis and higher adoption rates.

Key Growth Drivers of the Psoriasis Market

• Growing demand for biologic drugs and novel therapies
• Expansion of treatment options for moderate-to-severe psoriasis cases
• Increasing adoption of telemedicine and digital health solutions for patient monitoring
• Growing research and development in personalized medicine for psoriasis
• Rising investments by pharmaceutical companies in psoriasis treatment development

Psoriasis Market Trends

The psoriasis market is set to grow with a shift toward more effective and targeted treatments, especially biologics, which are proving to be highly effective for moderate-to-severe cases. There is a lot of interest in creating personalized therapies, which are treatments that are made to fit the patient genetics and disease. Oral systemic therapies and topical treatments are still changing, giving patients more choices. There is also a rise in combination therapies on the market. These are treatments that use more than one type of therapy to get better results. Another trend is the growing use of digital health platforms, such as mobile apps that help people keep track of their treatment and manage their symptoms.

Emerging Developments in the Psoriasis Market

The psoriasis market is evolving with significant advancements in biologics and targeted therapies, offering more efficient and less invasive treatment options. Gene therapy and stem cell-based therapies are becoming more popular as possible ways to get long-term remission and maybe even a cure. Biologic treatments, such as TNF inhibitors and IL-17/IL-23 inhibitors, are still the most common way to treat diseases. New drugs are coming out that work better and have fewer side effects. There is a lot more research going on into topical formulations for targeted therapy and more personalized oral medications. There is also a growing focus on diagnosing and treating the disease early so that it can be managed before it gets more severe.

List of Leading Companies in the Psoriasis Market

Some of the leading companies include:

• AbbVie Inc.
• Johnson & Johnson
• Novartis AG
• Amgen Inc.
• Eli Lilly and Co.
• Sanofi S.A.
• Bristol Myers Squibb

Frequently Asked Questions About the Market Study (FAQs):